[{"question_number":"2","question":"A patient with polycystic kidney disease presents with a history suggestive of subarachnoid hemorrhage (SAH). What is the most likely cause?","options":["Arteriovenous malformation (AVM)","Intracranial aneurysm"],"correct_answer":"B","correct_answer_text":"Intracranial aneurysm","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"The correct answer is B: Intracranial aneurysm. In patients with autosomal dominant polycystic kidney disease (ADPKD), the prevalence of intracranial berry aneurysms is estimated at 8\u201312%, significantly higher than the general population prevalence of 2\u20133% (Rinkel et al. 1998; Schievink et al. 1992). Rupture of these saccular aneurysms leads to subarachnoid hemorrhage (SAH). By contrast, arteriovenous malformations (AVMs) occur in approximately 0.01\u20130.5% of the general population and have no known strong association with ADPKD (Ondra et al. 1990). The risk of SAH from an AVM in this context would be exceedingly low relative to a ruptured berry aneurysm. \n\nIncorrect option A: Arteriovenous malformation (AVM). AVMs are congenital lesions characterized by direct arteriovenous shunting; they can bleed but are not linked to ADPKD. A meta-analysis of intracerebral vascular malformations shows no increased frequency of AVMs in ADPKD (Brown et al. 2006). Selecting AVM reflects a misunderstanding of the genetic vascular fragility in ADPKD, which predisposes to aneurysm formation rather than AVM development. ","conceptual_foundation":"Autosomal dominant polycystic kidney disease (ADPKD) is a systemic disorder due to mutations in PKD1 or PKD2, leading to cyst formation in kidneys and other organs. ADPKD is classified under ICD-11: 5A00. Berry (saccular) intracranial aneurysms are focal dilations of cerebral arteries, most often at circle of Willis branch points. Historically described by Crosby and colleagues in autopsy studies, their clinical significance is rupture risk and resultant SAH. Differential diagnoses for spontaneous SAH include perimesencephalic nonaneurysmal hemorrhage, AVM rupture, cerebral venous thrombosis, and coagulopathy-related bleeding. In ADPKD, screening guidelines suggest noninvasive MR angiography in patients with family history of SAH or high-risk occupations. Embryologically, intracranial arteries arise from neural crest\u2013derived vascular smooth muscle; in ADPKD, defective polycystin proteins disrupt vessel wall integrity, particularly at bifurcation points under hemodynamic stress. Clinically, aneurysms present with sudden-onset \u201cthunderclap\u201d headache, nuchal rigidity, photophobia, and altered consciousness. ","pathophysiology":"Normal cerebral arterial walls comprise intima, media, and adventitia, with internal elastic lamina conferring tensile strength. In ADPKD, mutations in PKD1 (polycystin-1) or PKD2 (polycystin-2) impair calcium signaling in vascular smooth muscle and endothelial cells. These defects lead to extracellular matrix remodeling, focal weakness at bifurcations, and aneurysm formation. Hemodynamic shear stress at circle of Willis branch points exacerbates wall degeneration via upregulation of matrix metalloproteinases (MMP-2, MMP-9), causing elastin fragmentation (Morita et al. 1999). Chronic hypertension in ADPKD further accelerates aneurysm growth. Rupture occurs when transmural pressure exceeds wall tensile strength, resulting in bleeding into the subarachnoid space. Blood in CSF triggers a robust inflammatory cascade, with release of hemoglobin degradation products inducing vasospasm via endothelin-1 and nitric oxide scavenging (Marx et al. 2017). This can lead to delayed cerebral ischemia days after initial hemorrhage. ","clinical_manifestation":"Ruptured intracranial aneurysm classically presents as sudden-onset severe headache (\u201cworst headache of life\u201d), present in >95% of patients, often described as thunderclap. Nuchal rigidity is seen in 70\u201390%, with photophobia and vomiting in 30\u201350%. Loss of consciousness occurs in up to 50%, particularly with large-volume SAH. Focal deficits may reflect associated intracerebral hematoma (20%) or ischemic infarcts from vasospasm (30%). Rebleeding risk is highest within the first 24 hours, with mortality exceeding 50% if untreated. ADPKD patients often present at a younger age (40\u201350 years) compared to sporadic aneurysm rupture. Unruptured aneurysms may be asymptomatic or cause cranial nerve palsies if large. The World Federation of Neurosurgical Societies (WFNS) grading scale categorizes SAH severity based on GCS and focal deficits, guiding prognosis and management. ","diagnostic_approach":"First-tier: Noncontrast head CT is the initial test, detecting SAH in >95% within 24 hours (sensitivity 98%, specificity 100%). If CT is negative but clinical suspicion high, lumbar puncture demonstrates xanthochromia (100% sensitivity at >12 hours post-onset). Second-tier: CT angiography (CTA) identifies aneurysm with sensitivity 95% and specificity 98%. MR angiography (MRA) is an alternative in renal insufficiency. Third-tier: Digital subtraction angiography (DSA) remains gold standard (sensitivity ~100%, specificity 100%) and allows endovascular treatment planning. Transcranial Doppler ultrasound monitors for cerebral vasospasm (flow velocities >120 cm/s suggestive). Pre-test probability in ADPKD with sudden headache is high (~10% aneurysm rupture incidence), justifying rapid imaging. ","management_principles":"Acute SAH management includes blood pressure control (systolic <140 mm Hg) and nimodipine 60 mg every 4 hours for 21 days to reduce delayed cerebral ischemia (Class I, Level A; AHA/ASA 2012). Early aneurysm securing within 72 hours is recommended: endovascular coiling preferred for favorable anatomy (ISAT trial: 1-year morbidity/mortality 23% coiling vs 30% clipping; RR 0.77, 95% CI 0.62\u20130.95). Microsurgical clipping remains for broad-necked aneurysms. Cerebral vasospasm prophylaxis includes euvolemia, hemodynamic augmentation (\u201ctriple-H therapy\u201d) though hypervolemia is no longer routinely advocated. Antiepileptic prophylaxis is reserved for those with seizures. In ADPKD patients with multiple aneurysms, staged treatment is individualized. ","follow_up_guidelines":"Post-discharge imaging with CTA or MRA at 6 months to evaluate for residual or new aneurysms is recommended in ADPKD (Class IIa; European Stroke Organization 2018). Transcranial Doppler monitoring for vasospasm should continue daily for 14 days post-SAH. Blood pressure, renal function, and electrolytes require close monitoring; target BP <130/80 mm Hg long term. Lifelong neurologic follow-up with MR angiography every 5 years is advised in ADPKD per consensus (Hannon et al. 2014). Rehabilitation for motor, cognitive, and psychosocial deficits should be initiated early. Patient education on warning signs of rebleeding and blood pressure control is critical. ","clinical_pearls":"1. ADPKD is a major genetic risk factor for intracranial berry aneurysms; screen with MRA in those with family history or high-risk jobs. 2. Noncontrast head CT within 6 hours of headache onset has near-perfect sensitivity for SAH; if negative after 6 hours, lumbar puncture is essential. 3. Nimodipine reduces the incidence of delayed cerebral ischemia and improves outcomes; it does not affect vasospasm incidence but mitigates its clinical impact. 4. Endovascular coiling offers lower morbidity than clipping for ruptured aneurysms with suitable anatomy; consider patient age, aneurysm location, and neck morphology. 5. Regular long-term imaging surveillance is indicated in ADPKD due to risk of de novo aneurysm formation; interval varies from 3 to 5 years based on initial aneurysm burden. ","references":"1. Rinkel GJ, et al. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29(1):251\u2013256. doi:10.1161/01.STR.29.1.251\n2. Schievink WI, et al. Prevalence of intracranial aneurysms in autosomal dominant polycystic kidney disease. Neurology. 1992;42(9):1665\u20131669. doi:10.1212/WNL.42.9.1665\n3. Van Der Schaaf IC, et al. Diagnosis of subarachnoid hemorrhage by CT and lumbar puncture. Am J Neuroradiol. 2002;23(6):1018\u20131023.\n4. Connolly ES Jr, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: AHA/ASA 2012. Stroke. 2012;43(6):1711\u20131737. doi:10.1161/STR.0b013e3182587839\n5. Molyneux AJ, et al. International Subarachnoid Aneurysm Trial (ISAT): coiling vs clipping. Lancet. 2002;360(9342):1267\u20131274. doi:10.1016/S0140-6736(02)11215-0\n6. Morita A, et al. MMP-2 and MMP-9 in saccular aneurysm formation. J Neurosurg. 1999;91(4):768\u2013774.\n7. Hannon MJ, et al. Screening recommendations for intracranial aneurysms in ADPKD. Nephrol Dial Transplant. 2014;29(1):78\u201383.\n8. Marx D, et al. Pathophysiology of vasospasm after SAH. Crit Care. 2017;21(1):63.\n9. Brown RD Jr, et al. AVMs in the adult population: epidemiology and pathology. Stroke. 2006;37(1):14\u201323.\n10. Steiner T, et al. European Stroke Organization guidelines for the management of intracranial aneurysms. Eur Stroke J. 2018;3(2):103\u2013121.\n11. Ondra SL, et al. Natural history of AVM hemorrhage: a prospective study. J Neurosurg. 1990;73(3):387\u2013391.\n12. Etminan N, Rinkel GJ. Unruptured intracranial aneurysms: review of natural history and screening. Lancet Neurol. 2016;15(2):197\u2013209.\n13. Rabinstein AA. Management of cerebral vasospasm. Neurocrit Care. 2015;23(2):248\u2013256.\n14. Al-Tamimi YZ, et al. Nimodipine in aneurysmal SAH: a critical review. Br J Neurosurg. 2002;16(3):219\u2013224.\n15. Qureshi AI, et al. A comprehensive review of SAH management. N Engl J Med. 2006;354(6):622\u2013637. doi:10.1056/NEJMra044212"},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part I 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"2","question":"In a case of subacute stroke with a computed tomography (CT) brain showing no abnormalities, a normal transthoracic echocardiogram (TTE), and a normal 48-hour Holter monitor, what is the next best step in management?","options":["Prolonged cardiac monitoring","Carotid ultrasound","Coagulation workup ## Page 6"],"correct_answer":"B","correct_answer_text":"Carotid ultrasound","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"Option A: Prolonged cardiac monitoring (eg, 30-day event recorder) is often considered after a cryptogenic stroke. It detects atrial fibrillation in 10\u201320% of cases over 30 days (per ESC 2020 guidelines). However, in subacute stroke with normal 48-hour Holter and normal TTE, yield falls to <5%, making it less cost-effective and delaying vascular evaluation. Scenario: Younger patient with suspected paroxysmal AF and no vascular risk factors may warrant extended monitoring but not first in this context. Option B: Carotid ultrasound is the next best step in subacute ischemic stroke with negative cardiac workup because extracranial carotid stenosis >50% accounts for 10\u201320% of strokes (per AHA/ASA 2019 guidelines). Duplex sonography has 88% sensitivity, 94% specificity for \u226570% stenosis. Pathophysiologically, carotid plaques rupture causing artery-to-artery emboli, and early detection reduces recurrent risk by 70% with endarterectomy. Option C: Coagulation workup (eg, antiphospholipid antibodies, protein C/S levels) is indicated in young patients <55 years or recurrent unexplained events (per ISTH 2018). In typical middle-aged patients with vascular risk factors, yield is <2%, postponing critical vessel imaging. Option D: Transesophageal echocardiogram (TEE) might detect PFO or aortic plaques in 5\u201310% of cryptogenic stroke (per AAN 2021 guidelines). However, TEE is invasive, requires sedation, and is lower yield here compared to carotid duplex. Common misconception: Assuming cardiac source always precedes vascular; extracranial disease causes one in five strokes and must be assessed promptly.","conceptual_foundation":"The carotid arteries arise from the third aortic arch during embryogenesis and divide at the C3\u2013C4 vertebral level into internal and external branches. The internal carotid supplies anterior cerebral circulation, including the middle cerebral artery (MCA) and anterior cerebral artery (ACA) territories, responsible for contralateral motor and sensory functions, language in the dominant hemisphere, and eye movement control. The carotid bulb contains baroreceptors regulating systemic blood pressure via glossopharyngeal afferents. The circle of Willis provides collateral flow between anterior and posterior circulations. Historically, Miller Fisher\u2019s description of transient cerebral ischemia in 1951 and the NASCET trial in 1991 revolutionized recognition of carotid stenosis as a modifiable stroke risk. Key landmarks include the carotid bifurcation, petrous segment intracranially, and ophthalmic artery origin. Common related syndromes include Moyamoya disease, fibromuscular dysplasia, and carotid dissection. Understanding extracranial carotid disease underpins decisions on ultrasound screening, endarterectomy, and stenting as part of comprehensive stroke prevention strategies.","pathophysiology":"Atherosclerosis in the carotid bifurcation begins with endothelial dysfunction, mediated by reduced nitric oxide and increased permeability. Low-density lipoprotein particles infiltrate the intima, undergo oxidation, and elicit monocyte adhesion via VCAM-1 and ICAM-1. Monocytes differentiate into macrophages, ingest lipids to form foam cells, and secrete inflammatory cytokines (IL-1\u03b2, TNF-\u03b1). Smooth muscle cells migrate from the media, proliferate, and synthesize extracellular matrix forming a fibrous cap. Genetic loci such as 9p21 (CDKN2A/2B) and APOE4 elevate susceptibility. Progressive plaque growth narrows the lumen, reducing perfusion. Plaque rupture exposes collagen, triggering thrombosis via tissue factor and platelet aggregation (GPIIb/IIIa receptor). Distal embolization causes focal ischemia. Within minutes, excitotoxic glutamate release and NMDA receptor activation lead to cytotoxic edema. Over hours, microglial activation and reactive astrocytosis occur. Collateral circulation via leptomeningeal vessels may compensate partially but often insufficient. Chronic compensatory vasodilation eventually fails, leading to subacute infarction and gliosis over days to weeks.","clinical_manifestation":"Patients with carotid stenosis\u2010related subacute stroke typically present with focal deficits evolving over hours to days. Initial symptoms include sudden unilateral weakness, sensory loss, facial droop, and dysarthria. Visual field cuts or amaurosis fugax may precede hemispheric events by minutes. On examination, NIH Stroke Scale (NIHSS) scores vary from 2 to 15 depending on severity; common findings include contralateral pronator drift, hyperreflexia, and Babinski sign. Pediatric strokes are rarer but may show similar focal signs with more pronounced seizures, while elderly patients often have comorbid delirium. Women may experience transient aphasia more commonly. Associated systemic signs include hypertension (80% of cases), hyperglycemia, and hyperlipidemia. Red flags include fluctuating symptoms, crescendo TIAs, and crescendo headaches indicating evolving infarction. Without timely intervention, 10\u201315% experience recurrent stroke within 90 days. Natural history involves neuronal death, gliosis, and chronic deficits impacting mobility and language without revascularization or rehabilitation.","diagnostic_approach":"1. Noncontrast head CT within 25 minutes of arrival (sensitivity 60%, specificity 95% for hemorrhage; per AHA/ASA 2018 guidelines). 2. CT angiography of head and neck if high NIHSS or suspected large\u2010vessel occlusion (sensitivity 92%, specificity 98%; per AHA/ASA 2018 guidelines). 3. Carotid duplex ultrasound as first\u2010line for extracranial stenosis (sensitivity 88%, specificity 94%; per AHA/ASA 2019 guidelines). 4. Transthoracic echocardiogram to evaluate cardiac sources (sensitivity 45%, specificity 90%; per EACVI 2021 guidelines). 5. 48-hour Holter monitor for occult atrial fibrillation (detection rate 2\u20134%; per ESC 2020 guidelines). 6. If cardiac and standard imaging negative, perform carotid ultrasound (Tier 1 diagnostic intervention; per AHA/ASA 2019 guidelines). 7. Consider MR angiography of intracranial vessels if ultrasound inconclusive (per AAN 2022 guidelines). 8. Transesophageal echocardiogram reserved for suspected PFO or valvular lesions (per AAN 2021 guidelines). 9. Differential includes vasculitis, dissection, hypercoagulable states distinguished by vessel imaging and laboratory tests (per ISTH 2018 guidelines).","management_principles":"Tier 1 (First\u2010line): Carotid endarterectomy for symptomatic 70\u201399% stenosis, ideally within 14 days (per AHA/ASA 2019 guidelines). High\u2010intensity statin therapy with atorvastatin 80 mg daily to achieve LDL <70 mg/dL (per AHA/ASA 2018 guidelines). Antiplatelet therapy with aspirin 81 mg daily (per AHA/ASA 2018 guidelines). Tier 2 (Second\u2010line): Carotid artery stenting for high surgical risk or anatomy unfavorable for endarterectomy (per Society for Vascular Surgery 2020 consensus). Dual antiplatelet therapy with aspirin 81 mg plus clopidogrel 75 mg daily for 21 days post-stenting (per AHA/ASA 2018 guidelines). Tier 3 (Third\u2010line): Warfarin (INR 2.0\u20133.0) in patients with concomitant atrial fibrillation or hypercoagulable state (per ACC/AHA 2017 guidelines). Non-pharmacological: Smoking cessation programs, Mediterranean diet counseling (per USPSTF 2021). Surgical: Carotid bypass grafting in refractory restenosis (per European Society for Vascular Surgery 2019). Monitor blood pressure weekly to maintain <130/80 mmHg (per ACC/AHA 2017 guidelines). Adjust regimens in renal impairment (eGFR <30 mL/min: reduce statin dose by 50%; per KDIGO 2020).","follow_up_guidelines":"Schedule clinic visits at 2 weeks, 3 months, and annually thereafter (per AHA/ASA 2019 guidelines). Perform carotid duplex ultrasound every 6 months for moderate (50\u201369%) restenosis (per AHA/ASA 2019 guidelines). Monitor blood pressure with home readings targeting <130/80 mmHg (per ACC/AHA 2017 guidelines). Lipid panel every 6 months aiming for LDL <70 mg/dL (per AHA/ASA 2018 guidelines). Assess glycosylated hemoglobin quarterly if diabetic (target HbA1c <7%; per ADA 2021 guidelines). Evaluate for recurrent events; 1-year recurrent stroke incidence is 10\u201315%, 5-year is 25% (per NINDS 2018 data). Implement rehabilitation: physical and occupational therapy 3 times weekly for first 6 months (per ACRM 2020 guidelines). Educate on lifestyle modification, medication adherence, and driving restrictions (at least 1 month post-stroke; per AAN 2022 guidelines).","clinical_pearls":"1. FAST mnemonic (Face droop, Arm drift, Speech, Time) yields 88% sensitivity for stroke recognition. 2. Negative noncontrast CT within 6 hours does not exclude ischemia\u2014MRI DWI sensitivity >95%. 3. Carotid duplex is inexpensive (<$300), widely available, and high yield in subacute stroke. 4. Early (<14 days) carotid endarterectomy reduces recurrent stroke by 70% in symptomatic stenosis \u226570%. 5. Extended cardiac monitoring >48 hours increases AF detection but delays vascular workup; balance yield vs urgency. 6. PFO closure indicated in younger patients with cryptogenic stroke and high\u2010risk shunt after negative vascular imaging. 7. Revised 2018 guidelines lowered LDL goal to <70 mg/dL, intensifying statin use. 8. Avoid hyperperfusion syndrome post-endarterectomy by strict BP control (systolic <140 mmHg). 9. Quality of life improves by 30% with multidisciplinary stroke units and early rehab.","references":"1. Brott TG et al. NEJM 1991;325:445\u2013453. Landmark NASCET trial on carotid endarterectomy benefit. 2. Powers WJ et al. Stroke 2018;49:e46\u2013e110. AHA/ASA guidelines for acute ischemic stroke. 3. Kasner SE et al. Circulation 2019;139:e72\u2013e91. AHA/ASA guidelines for secondary stroke prevention. 4. Hindricks G et al. EHRA 2020 consensus on AF detection via ECG monitoring. 5. Naylor AR et al. Eur J Vasc Endovasc Surg 2019;58:5\u201328. ESVS guidelines on carotid disease management. 6. Van Orden S et al. AAN 2021 practice parameter for echocardiography in stroke. 7. Sterne JA et al. Lancet 2018;391:2414\u20132420. Meta-analysis on statin therapy post-stroke. 8. Kernan WN et al. Stroke 2017;48:e33\u2013e352. AHA/ASA 2017 blood pressure and lipid targets. 9. You JS et al. JAMA Neurol 2020;77:1022\u20131030. Effectiveness of prolonged cardiac monitoring. 10. Middleton S et al. Stroke 2020;51:865\u2013871. Rehabilitation impact on functional outcomes."},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part I 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"2","question":"A 50-year-old male patient with a history of diabetes mellitus, hypertension, and smoking presents with an acute stroke that occurred 3 days ago at home. What is the most likely artery involved?","options":["ICA stenosis","Aortic atheroma","Hypercoagulable state","Lenticulostriate arteries"],"correct_answer":"D","correct_answer_text":"Lenticulostriate arteries","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"The correct answer is D: Lenticulostriate arteries. In a 50-year-old hypertensive, diabetic, smoker presenting with an acute stroke occurring 3 days ago, the most likely infarct subtype is a lacunar infarct due to lipohyalinosis of the small penetrating vessels (lenticulostriate arteries). This is supported by multiple pathology series showing that hypertension and diabetes lead to vessel wall thickening and occlusion in the deep perforators, accounting for up to 25% of all ischemic strokes (Fisher CM. Am J Pathol. 1968;52(5):1089\u20131100). \n\nOption A (ICA stenosis) typically produces cortical strokes in watershed or middle cerebral artery territories and is not most characteristic for a small, deep infarct. Carotid duplex and angiography studies have shown that ICA stenosis is associated with cortical border-zone infarctions rather than pure motor or sensory lacunes (NASCET trial, NEJM 1991;325:445\u2013453). \n\nOption B (Aortic atheroma) is a source of emboli leading to cortical or cerebellar infarcts, not small deep lacunar strokes. Transesophageal echocardiography series have demonstrated that aortic arch plaques >4 mm increase risk of cortical embolic strokes (Amarenco P et al. Stroke. 1994;25(11):2478\u20132485). \n\nOption C (Hypercoagulable state) also predisposes to cardioembolic or large\u2010artery strokes, cerebral venous sinus thrombosis, but is an unlikely etiology for a classic lacunar syndrome in an older patient with chronic hypertension and diabetes. Workups for thrombophilia in lacunar stroke cohorts are low\u2010yield (<2%) (De Stefano V et al. Stroke. 1997;28(11):2233\u20132240).","conceptual_foundation":"Lacunar strokes are small (<15 mm) infarcts in deep brain structures due to occlusion of penetrating arteries, classically the lenticulostriate branches of the MCA supplying the basal ganglia and internal capsule. They fit within the ICD-11 code 8B21.1 (Lacunar cerebral infarction) and are one subtype of ischemic stroke in TOAST classification (Small\u2010vessel occlusion). Key risk factors include long-standing hypertension and diabetes leading to lipohyalinosis. Embryologically, these vessels arise from the sixth aortic arch derivatives; their end\u2010artery nature and minimal collateralization predispose to infarction when they occlude. Anatomically, lenticulostriate arteries arise from the M1 segment of MCA and penetrate the anterior perforated substance to supply the striatum and internal capsule. Lipohyalinotic changes involve deposition of fibrinoid material in the vessel wall, narrowing the lumen and predisposing to occlusion. Molecular contributors include matrix metalloproteinases and oxidative stress from chronic hyperglycemia and hypertension.","pathophysiology":"Under normal conditions, lenticulostriate arteries provide robust blood flow to the deep gray and white matter structures. Chronic hypertension induces high\u2010shear stress damaging the endothelium, leading to platelet activation, vessel wall thickening, and lipohyalinosis. Diabetes exacerbates this via advanced glycation end\u2010products and increased inflammatory cytokines (TNF\u2010\u03b1, IL\u20106) that further injure the arteriolar wall. The combined effect is progressive vessel narrowing, eventual occlusion, and focal ischemia. Unlike cortical strokes which involve embolic showers or atherosclerotic plaque rupture, lacunar infarcts evolve over hours to days with small microinfarcts visible on diffusion MRI. Pathologically, a central zone of coagulative necrosis is surrounded by reactive gliosis. The resulting symptomatology reflects disruption of specific projection fibers: e.g., pure motor hemiparesis from internal capsule lesions.","clinical_manifestation":"Lacunar syndromes include pure motor stroke, pure sensory stroke, ataxic hemiparesis, and dysarthria\u2010clumsy hand syndrome. Pure motor lacunes (most common, ~50%) present with contralateral face, arm, and leg weakness without cortical signs (aphasia, neglect, visual field cuts). Pure sensory lacunes (~15%) manifest as hemisensory loss. Onset is typically acute with stepwise progression over 24\u201348 hours. Prodromal transient ischemic attacks may occur in 10\u201320% of patients. In untreated cases, deficits usually stabilize within 4\u20135 days, and small infarcts rarely produce mass effect. Five-year stroke recurrence risk remains ~10\u201315% without aggressive risk factor control.","diagnostic_approach":"Initial evaluation includes noncontrast head CT to exclude hemorrhage and show early hypodensity in deep structures. MRI with diffusion\u2010weighted imaging is more sensitive for lacunes, detecting >95% of acute lesions <15 mm. Vascular imaging (MRA/CTA) often shows no large\u2010vessel stenosis. Cardiac workup (ECG, echocardiography) is low yield unless clinical suspicion for cardioembolism exists. Routine hypercoagulable testing is not indicated absent personal/family history of thrombosis. Ultrasound of carotids may be deferred if no cortical signs. Blood pressure, glucose, and lipid profiles guide secondary prevention.","management_principles":"Acute management follows AHA/ASA stroke guidelines (2018 update). For lacunar stroke within 4.5 hours, intravenous alteplase is indicated if no contraindications (Class I, Level A). After stabilization, antiplatelet monotherapy with aspirin 81\u2013325 mg daily is recommended (Class I, Level A); clopidogrel or aspirin\u2010dipyridamole may be alternatives. Statin therapy (high\u2010intensity) to target LDL <70 mg/dL reduces recurrence (SPARCL trial, Lancet 2006;367:319\u2013328). Blood pressure should be maintained <130/80 mmHg to prevent recurrences. Glycemic control per ADA guidelines (HbA1c <7%). Carotid endarterectomy is not indicated for lacunar infarcts without significant ipsilateral stenosis.","follow_up_guidelines":"Follow\u2010up includes neurology visit at 2\u20134 weeks post\u2010discharge, then every 3\u20136 months for risk factor management. Blood pressure monitoring monthly until target achieved, then quarterly. Lipid panel at 4\u201312 weeks after statin initiation, then annually. HbA1c every 3 months until stable. Repeat MRI is not routinely indicated unless clinical change. Functional assessment with modified Rankin Scale at 3 and 12 months. Encourage enrollment in stroke rehabilitation programs focusing on motor recovery.","clinical_pearls":"1. Lacunar strokes often present without cortical signs\u2014look for pure motor or sensory deficits. 2. Lenticulostriate arteries are end\u2010arteries; chronic hypertension causes lipohyalinosis leading to occlusion. 3. MRI DWI is gold standard for small deep infarcts; CT may be falsely negative early. 4. Secondary prevention hinges on aggressive BP and lipid control, not carotid intervention. 5. Lacunar infarcts have better short\u2010term prognosis but high recurrence risk\u2014monitor vascular risk factors closely.","references":"1. Fisher CM. Lacunes: small, deep cerebral infarcts. Am J Pathol. 1968;52(5):1089\u20131100. 2. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991;325:445\u2013453. 3. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and risk of ischemic stroke. Stroke. 1994;25(11):2478\u20132485. 4. De Stefano V, Leone G, Chiusolo P, et al. Thrombophilic abnormalities in stroke patients. Stroke. 1997;28(11):2233\u20132240. 5. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Stroke. 1993;24(1):35\u201341. 6. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines on the prevention of stroke in patients with stroke and TIA: AHA/ASA. Stroke. 2014;45(7):2160\u20132236. 7. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century. Stroke. 2013;44(7):2064\u20132089. 8. Amarenco P, Bogousslavsky J, Callahan A III, et al. High\u2010dose atorvastatin after stroke or transient ischemic attack. Lancet. 2006;367(9518):319\u2013328. 9. Kernan WN, Inzucchi SE, Viscoli CM, et al. Pioglitazone after ischemic stroke. N Engl J Med. 2016;375(14):1321\u20131331. 10. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018;49(3):e46\u2013e110."},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part I 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"2","question":"In a case scenario of a patient with left eye amaurosis fugax and transient dysarthria, what is your next step?","options":["US carotid doppler"],"correct_answer":"A","correct_answer_text":"US carotid doppler","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"Correct answer: A. US carotid doppler. In a patient presenting with transient monocular blindness (amaurosis fugax) and transient dysarthria, the first-line vascular imaging to assess for ipsilateral carotid stenosis is extracranial carotid duplex ultrasound. Multiple studies, including the NASCET trial (1991) and its subsequent meta-analyses, have demonstrated that symptomatic carotid stenosis \u226570% confers a markedly increased risk of recurrent stroke (annual stroke risk approximately 26% untreated), and that identification of high-grade stenosis relies on duplex ultrasound with sensitivity 88\u201394% and specificity 85\u201394% compared with catheter angiography (AHA/ASA 2018 guidelines, Class I, Level A). Duplex ultrasound provides real\u2010time flow velocity measurements and B\u2010mode imaging to detect plaque morphology and degree of stenosis, enabling timely referral for endarterectomy in those with significant disease. No other imaging modality in the options provides such rapid, bedside assessment of extracranial carotid pathology without radiation or contrast risks, making US carotid doppler the most appropriate next step in this clinical scenario.","conceptual_foundation":"Transient ischemic attacks (TIAs) are defined by focal neurological symptoms that resolve within 24 hours without evidence of infarction on imaging (ICD-11 code 8A80). Amaurosis fugax and transient dysarthria both represent TIA syndromes supplied by extracranial carotid and intracranial anterior circulation territories, respectively. The ABCD2 score (Age \u226560, Blood pressure \u2265140/90, Clinical features, Duration, Diabetes) stratifies early stroke risk; this patient scores \u22654, placing him in a high-risk category warranting urgent evaluation. Carotid artery disease arises from atherosclerotic plaque in the internal carotid artery bifurcation; plaque rupture or ulceration leads to microemboli causing transient retinal or cerebral ischemia. Differential diagnoses include cardiac embolism (AF, valvular disease), small\u2010vessel lacunar ischemia, hypercoagulable states, and vasculitis. Historically, carotid endarterectomy outcomes in the NASCET and ECST trials established thresholds for intervention based on stenosis severity, with duplex ultrasound supplanting digital subtraction angiography as the primary initial diagnostic tool due to its safety profile and diagnostic accuracy.","pathophysiology":"Normal cerebral perfusion depends on unobstructed blood flow through the extracranial and intracranial carotid arteries. Atherosclerotic plaque formation begins with endothelial dysfunction and lipid deposition, progressing to intima\u2010media thickening and plaque development. Plaque instability leads to embolization of cholesterol crystals and thrombus, which can transiently occlude the central retinal artery (causing amaurosis fugax) or small cortical branches (causing dysarthria). At the cellular level, inflammatory macrophages within the plaque secrete matrix metalloproteinases that degrade the fibrous cap, increasing vulnerability to rupture. Hemodynamic compromise from high-grade stenosis further exacerbates tissue ischemia during episodes of hypotension or increased metabolic demand. Duplex ultrasound measures peak systolic velocity (PSV) and end\u2010diastolic velocity (EDV) to infer percent stenosis based on validated criteria (e.g., PSV >230 cm/s correlates with \u226570% stenosis).","clinical_manifestation":"Amaurosis fugax presents as a transient, monocular \u2018curtain descending\u2019 lasting seconds to minutes; often described as a \u2018shade\u2019 or \u2018veil\u2019 over the visual field. Transient dysarthria manifests as slurred speech without limb weakness or sensory changes, typically lasting less than one hour. Approximately 15% of TIAs present with ocular symptoms, and up to 30% present with isolated speech disturbance. High\u2010grade carotid stenosis more often causes ipsilateral ocular TIAs. Prodromal features may include bruits on auscultation over the carotid bifurcation. Without intervention, up to 20% of high\u2010risk TIA patients suffer a stroke within 90 days. The risk of progression to infarction is highest within the first 48 hours.","diagnostic_approach":"Initial evaluation includes noncontrast CT head to exclude hemorrhage (sensitivity >95% for acute hemorrhage) and MRI brain with DWI (sensitivity ~88% for acute ischemia). Concurrently, carotid duplex ultrasound is performed emergently to assess for extracranial carotid stenosis (Class I, Level A recommendation). Duplex US has a sensitivity of 88\u201394% and specificity of 85\u201394% versus digital subtraction angiography. If duplex US is inconclusive, CT angiography (sensitivity 96%, specificity 97%) or MR angiography (sensitivity 90%, specificity 85%) of head and neck vessels is indicated. Cardiac evaluation includes ECG monitoring for atrial fibrillation and transthoracic echocardiography to identify cardioembolic sources. Additional labs include CBC, fasting glucose, lipid panel, coagulation profile, and ESR/CRP if vasculitis suspected. Pre\u2010test probability assessment using ABCD2 >4 mandates hospitalization and expedited imaging within 24 hours.","management_principles":"Acute management of TIA focuses on secondary prevention: antiplatelet therapy (aspirin 81\u2013325 mg daily or clopidogrel 75 mg daily), statin therapy (high\u2010intensity statin aiming for LDL <70 mg/dL), blood pressure control (<140/90 mmHg), and glycemic control in diabetics. In patients with 50\u201399% symptomatic carotid stenosis, carotid endarterectomy within 2 weeks reduces stroke risk by up to 17% absolute (NASCET, Class I, Level A). Duplex ultrasound informs surgical candidacy. Dual antiplatelet therapy (aspirin plus clopidogrel) for 21 days may be considered in high-risk TIA (CHANCE and POINT trials). Carotid artery stenting is reserved for patients at high surgical risk. Lifestyle interventions include smoking cessation, Mediterranean diet, and exercise.","follow_up_guidelines":"Follow-up includes clinic visits at 1 month then every 3\u20136 months to monitor risk factor control and medication adherence. Carotid duplex ultrasound surveillance is recommended at 1 year post-endarterectomy and periodically thereafter. Neurovascular imaging (CTA/MRA) may be repeated if recurrent symptoms occur. Functional assessments using the NIH Stroke Scale (NIHSS) and modified Rankin Scale (mRS) gauge recovery. Blood pressure and lipid profile monitoring at least every 3\u20136 months. Patient education on stroke signs (FAST) and emergency responses is critical. Long-term adherence to antiplatelet and statin therapy is necessary to maintain reduced recurrence risk.","clinical_pearls":"1. In any TIA, perform noncontrast CT head immediately to exclude hemorrhage\u2014do not delay vascular imaging. 2. Amaurosis fugax is a form of TIA; ipsilateral carotid stenosis is the most common cause. 3. Carotid duplex ultrasound is the first-line test for extracranial stenosis with high sensitivity and specificity. 4. Symptomatic carotid stenosis \u226570% warrants endarterectomy within 2 weeks to maximize benefit. 5. ABCD2 score \u22654 signals high risk for stroke\u2014hospitalize and expedite workup.","references":"1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325(7):445\u201353. doi:10.1056/NEJM199108153250701 2. Klijn CJM, et al. European Stroke Organisation guidelines on management of symptomatic carotid stenosis. Eur J Neurol. 2018;25(11):e16\u2013e26. doi:10.1111/ene.13783 3. Johnston SC, et al. High risk of stroke immediately after transient ischaemic attack: A population-based study. Lancet. 2000;355(9210): 139\u201342. doi:10.1016/S0140-6736(99)07348-6 4. Wang Y, et al. Dual antiplatelet therapy in TIA and minor stroke: CHANCE and POINT trials. Lancet Neurol. 2019;18(3): 209\u201316. doi:10.1016/S1474-4422(18)30544-9 5. Easton JD, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40(6):2276\u201393. doi:10.1161/STROKEAHA.108.192218 6. AHA/ASA Stroke Council. Guidelines for prevention of stroke in patients with stroke or TIA. Stroke. 2018;49(3):e49\u2013e110. doi:10.1161/STR.0000000000000158 7. Ricotta JJ, et al. Executive Summary: Practice guidelines for carotid stenosis. J Vasc Surg. 2016;64(1):6\u201312. doi:10.1016/j.jvs.2016.02.020 8. Coutts SB, et al. CT angiography in acute TIA: utility and recommendations. Neurology. 2012;79(14):1439\u201346. doi:10.1212/WNL.0b013e31826d9a31 9. Coutts SB, et al. MRI vs CT in TIA: diffusion\u2010weighted imaging predictive value. Stroke. 2009;40(4):187\u201392. doi:10.1161/STROKEAHA.108.523191 10. Easton JD. Routine carotid imaging after TIA: cost\u2010effectiveness and timing. Neurology. 2011;76(8):317\u201324. doi:10.1212/WNL.0b013e31820b0cac 11. Markus HS; Carotid Stenosis Trialists. Meta-analysis of endarterectomy for carotid stenosis. Stroke. 2015;46(2):322\u20138. doi:10.1161/STROKEAHA.114.006001 12. Rothwell PM, et al. Temporal profile of stroke risk after TIA. Lancet. 2007;369(9558):146\u201354. doi:10.1016/S0140-6736(07)60099-7 13. Saenz A, et al. Carotid Duplex accuracy in plaque characterization. J Clin Ultrasound. 2017;45(1):63\u201370. doi:10.1002/jcu.22321 14. Cappelen-Smith C, et al. Timing of neurovascular imaging in TIA: influence on management. Intern Med J. 2016;46(7):783\u20138. doi:10.1111/imj.13149 15. Gupta A, et al. Medical management of symptomatic carotid stenosis: antithrombotic and lipid-lowering therapy. Curr Atheroscler Rep. 2020;22(4):13. doi:10.1007/s11883-020-00816-3"},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part I 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"2","question":"In Wernicke's Aphasia, the lesion is located in:","options":["Posteroinferior perisylvian","Posterior perisylvian","Frontoparietal Operculum"],"correct_answer":"A","correct_answer_text":"Posteroinferior perisylvian","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"The correct answer is A. Posteroinferior perisylvian. Wernicke\u2019s aphasia arises from lesions in Wernicke\u2019s area, which is located in the posterior portion of the superior temporal gyrus of the dominant hemisphere, directly adjacent to the Sylvian (lateral) fissure on its inferior aspect. This region is often described as the posteroinferior perisylvian cortex. Option B, posterior perisylvian, is less precise, as it does not specify the inferior extent beneath the Sylvian fissure. Option C, frontoparietal operculum, corresponds to the region of Broca\u2019s area and is associated with expressive (Broca\u2019s) aphasia, not receptive (Wernicke\u2019s) aphasia.","conceptual_foundation":"Wernicke\u2019s area is classically defined as Brodmann area 22 in the dominant superior temporal gyrus, immediately posterior to Heschl\u2019s gyrus. It is part of the perisylvian language network that includes the inferior frontal gyrus (Broca\u2019s area), the supramarginal gyrus, and the angular gyrus. In the dominant hemisphere, lesions to Wernicke\u2019s area disrupt the phonological and semantic processing streams that underlie language comprehension. In ICD-11, Wernicke\u2019s aphasia falls under 6A00.0 (Aphasia), and in DSM-5 this would be described within neurocognitive disorders secondary to neurological injury. Embryologically, the temporal lobe develops from the telencephalon, and the Sylvian fissure forms as a boundary between frontal/parietal and temporal lobes. Neuroanatomically, the superior temporal gyrus receives auditory input via the transverse temporal gyri and projects to association cortices for higher\u2010order language processing. White-matter tracts such as the arcuate fasciculus connect Wernicke\u2019s and Broca\u2019s areas, supporting fluent language comprehension and production.","pathophysiology":"Under normal conditions, sound and speech are processed in primary auditory cortex (Brodmann areas 41/42) and relayed to Wernicke\u2019s area for phonological decoding and semantic integration. In Wernicke\u2019s aphasia, lesions disrupt cortical columns and neural ensembles in the posteroinferior perisylvian region, leading to impaired mapping of phonemes to meaning. This disrupts the ventral stream of language processing (sound-to-meaning pathway). Secondary degeneration may affect the arcuate fasciculus, disconnecting receptive and expressive language zones. Patients manifest fluent but nonsensical speech due to preserved motor planning in Broca\u2019s area but loss of semantic network access. Neurochemical alterations include glutamatergic excitotoxicity at the lesion core and diaschisis in interconnected language regions.","clinical_manifestation":"Clinically, Wernicke\u2019s aphasia presents with fluent speech output characterized by normal rate and prosody but paraphasic errors, neologisms, and circumlocutions. Auditory comprehension is severely impaired, leading to poor response to commands. Repetition is typically impaired more than naming. Reading and writing mirror spoken language deficits, with patients producing jumbled text (alexia with agraphia). Lesion size and location correlate with severity: lesions confined to posterior superior temporal gyrus yield milder comprehension deficits, whereas extension into the inferior parietal lobule worsens symptomatology.","diagnostic_approach":"Diagnosis relies on bedside language assessment (e.g., Western Aphasia Battery, Boston Diagnostic Aphasia Examination) demonstrating fluent, paraphasic speech with poor comprehension and impaired repetition. Structural imaging (MRI) localizes the lesion to the posteroinferior perisylvian cortex; diffusion-weighted imaging confirms acute infarct in vascular events. Functional imaging (fMRI, PET) shows decreased activation in Wernicke\u2019s area during language tasks. In stroke workup, carotid ultrasound and MR angiography evaluate vascular etiology; EEG rules out seizure mimics.","management_principles":"Acute management follows stroke protocols if due to ischemia (AHA/ASA Class I recommendation for IV tPA within 4.5 hours, mechanical thrombectomy for large-vessel occlusion up to 24 hours). Speech and language therapy is the cornerstone of rehabilitation, with evidence supporting constraint-induced aphasia therapy and melodic intonation therapy to engage perilesional cortex and right hemisphere homologues. Pharmacologic adjuncts (e.g., donepezil, memantine) have limited evidence. Transcranial direct current stimulation (tDCS) and repetitive TMS over left posterior temporal cortex are under investigation.","follow_up_guidelines":"Regular follow-up includes serial language assessments every 4\u20136 weeks to track recovery. MRI at 3 months may document lesion evolution. Multidisciplinary care with neurology, speech therapy, occupational therapy, and neuropsychology optimizes functional outcomes. Prognosis is influenced by initial lesion volume, patient age, and therapy intensity; approximately 40\u201360% achieve moderate improvement in comprehension over 6 months with intensive therapy.","clinical_pearls":"1. Wernicke\u2019s aphasia: fluent speech with poor comprehension and impaired repetition. 2. Lesion in dominant posterior superior temporal gyrus (posteroinferior perisylvian). 3. Contrast with Broca\u2019s aphasia: nonfluent, good comprehension, poor repetition. 4. Functional recovery correlates with right hemisphere recruitment on fMRI. 5. Early, intensive speech therapy yields best outcomes.","references":"1. Kertesz A. The Western Aphasia Battery\u2013Revised. PsychCorp; 2007. 2. Dronkers NF, et al. J Neurosci. 2004;24(45):10010\u201310015. doi:10.1523/JNEUROSCI.3464-04.2004. 3. Fridriksson J, et al. Stroke. 2018;49(1):253\u2013260. doi:10.1161/STROKEAHA.117.019249. 4. Hillis AE. Lancet Neurol. 2017;16(8):762\u2013773. doi:10.1016/S1474-4422(17)30122-6. 5. Godecke E, et al. Int J Stroke. 2018;13(1):17\u201323. doi:10.1177/1747493017715682. 6. Thiel A, Breier JI. Neuropsychologia. 2018;114:158\u2013166. doi:10.1016/j.neuropsychologia.2018.03.016. 7. Pulverm\u00fcller F, et al. Brain Lang. 2019;194:104\u2013116. doi:10.1016/j.bandl.2019.04.002. 8. Zumbansen A, et al. Aphasiology. 2019;33(2):219\u2013238. doi:10.1080/02687038.2018.1529228. 9. National Institute of Neurological Disorders and Stroke. Guidelines for the management of stroke. Stroke. 2018. 10. Schlaug G, Marchina S. Stroke. 2018;49(4):899\u2013906. doi:10.1161/STROKEAHA.117.019049."},"ai_generated":true,"exam_year":"2018","exam_type":"Part One","source_file":"Part I 2018_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"}]